R.R. Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 50.00 Cr
as on 12-12-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 250.76 Cr
as on 12-12-2024
- Satisfied Charges ₹ 166.00 Cr
as on 12-12-2024
- Revenue -95.16%
(FY 2021)
- Profit -194.48%
(FY 2021)
- Ebitda -184.10%
(FY 2021)
- Net Worth -4.16%
(FY 2021)
- Total Assets 29.07%
(FY 2021)
About R.R. Lifesciences
The Corporate was formerly known as Ramratan Real Estate Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 50.00 Cr.
The company currently has active open charges totaling ₹250.76 Cr. The company has closed loans amounting to ₹166.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at R.R. Lifesciences Private Limited India is Akanksha Handoo as COMPANY SECRETARY. Sharan Agrawal and Rahul Agrawal serve as directors at the Company.
- CIN/LLPIN
U85100CT2011PTC022389
- Company No.
022389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Durg, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at R.R. Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akanksha Handoo | Company Secretary | 25-Apr-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharan Agrawal  | Director | 25-Mar-2011 | Current |
| Rahul Agrawal | Director | 25-Mar-2011 | Current |
Financial Performance and Corporate Structure Insights of R.R. Lifesciences.
R.R. Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 95.16% decrease. The company also saw a substantial fall in profitability, with a 194.48% decrease in profit. The company's net worth dipped by a decrease of 4.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.R. Lifesciences?
In 2023, R.R. Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R.K. Associates & Hoteliers Private LimitedActive 15 years 9 monthsSharan Agrawal is a mutual person
Comesum Retail & Hospitality Private LimitedActive 11 years 11 monthsRahul Agrawal is a mutual person
R.K. Restaurant & Food Services Private Limited.Active 16 years 29 daysSharan Agrawal and Rahul Agrawal are mutual person
- Fair Residency Private LimitedActive 14 years 19 days
Sharan Agrawal and Rahul Agrawal are mutual person
- R.K. Medilife Private LimitedActive 17 years 5 months
Sharan Agrawal and Rahul Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Mar 2023 | ₹0.41 M | Open |
Hdfc Bank Limited Creation Date: 16 Mar 2023 | ₹14.50 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Feb 2023 | ₹232.93 Cr | Open |
How Many Employees Work at R.R. Lifesciences?
R.R. Lifesciences has a workforce of 268 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.R. Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.R. Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
